Home

2025 Review Course

Latest Discussions

  • Kristi, Fortunately you are nearing the end of his intensive therapy although you will be missing DI part 2 and IM2 if I read this all correctly.IThe CRLF2 kids don't do all so well with a high relapse rate as you know and don't know whether he is high ...

  • Hi, I have been involved with an adolescent with HR B-cell ALL who developed necrotizing fasciitis of the left leg during the End of Consolidation. We had to delay care for ~4 weeks. I did try to proceed with IM-I (HDMTX) but she then had wound re-opening ...

  • Hi, I am currently caring for a 16 year old adolescent with a recent diagnosis of subependymal giant cell astrocytoma, WHO Grade 1 but lacks any minor features and lacks genetic mutations in the TCS1 or TCS2 genes (negative through Invitae). Baseline ...

Announcements

  • Register Early and Save on the 2025 Review Course

    Make the most of your Review Course experience and save by registering early! Register by January 7, 2025 to save $250 as an early bird, and save an additional $300 on registration as an ASPHO member, regardless of when you register. more

Most Active Members